Skip to content
Menu

Zimmer Biomet Holdings, Inc. ZBH

Full chart Compare
Set alert

Price alert · ZBH

All alert types
102.16 USD +0.07 (+0.07%)

As ofNov 18, 2026, 11:55 AM EST

100.71 Day range 103.53
79.58 52-week range 110.15
YTD
+13.61%
1 year
+14.68%
Market cap
19.34B
Revenue (ttm)
8.57B
Profit margin
8.95%
EPS (ttm)
3.96
Shares out
189.25M
P/E ratio
25.81
Forward P/E
11.37
Dividend
0.96 (0.92%)
Ex-dividend date
Sep 30, 2026
YTD return
+13.61%
1-year return
+14.68%
Volume
574.71K
Avg volume
2.10M
Open
100.95
Previous close
102.09
Day's range
100.71 – 103.53
52-week range
79.58 – 110.15
Beta
0.47
Analysts
Buy
Price target
117.38 (+14.9%)
Earnings date
Feb 9, 2027
50-day average
95.83

5D -6.19 (-5.71%)

100102.50105107.50ThuFriMonTueWed102.17

Key statistics

200-day average
92.60
Enterprise value
26.43B
PEG ratio
2.17
Price / sales
2.25
Price / book
1.53
Payout ratio
24.24%
Revenue growth
3.10%
Free cash flow
1.44B
Total cash
426.90M
Total debt
7.66B
Return on equity
6.03%
Short % of float
5.49%

Fundamental scorecard

19 of 25 checks passed on ZBH’s reported financials

ValueGrowthProfitabilityHealthDividend

19of 25 checks passed

  • Value 4 of 5
  • Growth 4 of 5
  • Profitability 4 of 5
  • Financial health 3 of 5
  • Dividend 4 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ZBH Revenue — quarterly 2.06B
ZBH Net income — quarterly 191.60M
ZBH EPS — quarterly 1.01

Earnings

ZBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 20262.49———
Nov 4, 2026Sep 30, 20261.881.90+0.02+1.06%
Aug 5, 2026Jun 30, 20262.012.07+0.06+2.99%
Apr 28, 2026Mar 31, 20261.862.09+0.23+12.37%
Feb 10, 2026Dec 31, 20252.382.42+0.04+1.68%
Nov 5, 2025Sep 30, 20251.871.90+0.03+1.60%

Upgrades / downgrades

ZBH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 17, 2026Wells FargoupEqual-WeightOverweight
Nov 16, 2026BMO CapitalmainMarket PerformMarket Perform
Nov 16, 2026StifelmainBuyBuy
Nov 9, 2026BarclaysmainEqual-WeightEqual-Weight
Nov 5, 2026UBSmainBuyBuy
Nov 5, 2026JP MorganmainNeutralNeutral

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ZBH — it syncs with the Stock Master app.

Insider holders

ZBH insider holders
InsiderRelationLatest transactionDateShares held
BEZJAK MARKOfficerConversion of Exercise of derivative securityMar 5, 202513,134
ELLINGSON RACHEL H.OfficerConversion of Exercise of derivative securityFeb 19, 202511,906
NOOR JEHANZEBOfficerConversion of Exercise of derivative securityMar 31, 20265,151
PHIPPS CHAD FOfficerSaleSep 3, 202665,231
STELLATO PAUL AOfficerConversion of Exercise of derivative securityMar 5, 20265,582
TORNOS IVANChief Executive OfficerConversion of Exercise of derivative securityMar 5, 202683,191

Institution ownership

ZBH institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.12.01%22,732,1372.32BSep 29, 2026
Blackrock Inc.8.25%15,612,3961.59BSep 29, 2026
Vanguard Capital Management LLC6.59%12,479,8661.27BSep 29, 2026
Harris Associates L.P.6.46%12,230,0881.25BSep 29, 2026
Capital International Investors5.74%10,859,3521.11BSep 29, 2026
State Street Corporation4.69%8,883,451907.09MSep 29, 2026

Fund ownership

ZBH fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.22%15,549,9001.59BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.25%6,141,461627.10MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund3.10%5,867,350599.12MJul 30, 2026
HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Fund2.97%5,621,292573.99MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.65%5,010,793511.65MJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.44%4,610,277470.76MSep 29, 2026